253 related articles for article (PubMed ID: 11177300)
1. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the indices affecting the phospholipid structure of high density lipoprotein subfractions in ischemic heart disease].
Pham Thi My; Torkhovskaia TI; Ozerova IN; Polesskiĭ VA; Kurdanov KhA
Vopr Med Khim; 1981; 27(5):701-6. PubMed ID: 7314590
[TBL] [Abstract][Full Text] [Related]
3. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
Haviar V; Riecanský L; Kusá O; Luknárová O
Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417
[No Abstract] [Full Text] [Related]
4. Medical Grand Rounds. Hyperlipidemia and low HDL Cholesterol.
J Tenn Med Assoc; 1980 Sep; 73(9):641-6. PubMed ID: 7442237
[No Abstract] [Full Text] [Related]
5. The lowered serum phospholipids in alpha-lipoprotein in patients with atherosclerosis.
Kajiyama G; Mizuno T; Matsuura C; Yamada K; Suzukawa M
Hiroshima J Med Sci; 1974 Dec; 23(4):229-36. PubMed ID: 4377736
[No Abstract] [Full Text] [Related]
6. [Effects of age, sex and obesity on high density lipoprotein cholesterol and phospholipids in normal subjects and in patients with ischemic heart disease (author's transl)].
Tsuji M; Murao M; Ide H; Kobayashi T
Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):639-46. PubMed ID: 7206303
[No Abstract] [Full Text] [Related]
7. [Cholesterol-acceptor properties of high-density lipoproteins with respect to erythrocyte membranes in patients with ischemic heart disease].
Torkhovskaia TI; Gorbatenkova EA; Dudaev VA; Chesnokova IaM; Azizova OA
Vopr Med Khim; 1986; 32(2):101-5. PubMed ID: 3010565
[TBL] [Abstract][Full Text] [Related]
8. Nutrient--high-density lipoprotein relationships: an overview.
Rifkind BM
Prog Biochem Pharmacol; 1983; 19():89-109. PubMed ID: 6338526
[No Abstract] [Full Text] [Related]
9. [Impairment of cholesterol-acceptor function of high density lipoproteins in patients with ischemic heart disease].
Parfenova NS; Petrova-Maslakova LG; Kuznetsov AS; Ioffe DV; Alksnis EG
Vopr Med Khim; 1988; 34(2):42-6. PubMed ID: 3400190
[TBL] [Abstract][Full Text] [Related]
10. [Total cholesterol and high-density lipoprotein cholesterol in sensorineural deafness].
Nuti D; Cosentino G; Vessio G
Quad Sclavo Diagn; 1983 Mar; 19(1):129-33. PubMed ID: 6675042
[TBL] [Abstract][Full Text] [Related]
11. [Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease (author's transl)].
Li ZX
Zhonghua Yi Xue Za Zhi; 1982 Jan; 62(1):13-7. PubMed ID: 6805908
[No Abstract] [Full Text] [Related]
12. [Various reasons for changes in the phospholipid composition of high density lipoproteins in hypoalphacholesterolemia].
Gerasimova EN; Nikitin IuP; Ozerova IN; Shcherbakova IA; Sidorenko BA
Vopr Med Khim; 1985; 31(3):132-6. PubMed ID: 4024525
[TBL] [Abstract][Full Text] [Related]
13. [Effect of antiatherosclerosis diet with different total caloric value on the level of high density lipoproteins cholesterol in patients with ischemic heart disease].
Samsonov MA; Frolova IA; Paramonova EG; Zubenko AD; Sirota II
Vopr Pitan; 1981; (5):15-20. PubMed ID: 7314609
[No Abstract] [Full Text] [Related]
14. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association.
Arteriosclerosis; 1984; 4(4):443A-468A. PubMed ID: 6466199
[No Abstract] [Full Text] [Related]
15. [Anti-atherogenic effect of enterosorption in patients with diabetes mellitus].
Bodnar PN; Pristupiuk AM; Romashkan SV; Novopashennaia VV
Ter Arkh; 1987; 59(11):26-9. PubMed ID: 3441861
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
Perova NV; Ozerova IN; Paramonova IV; Olfer'ev AM; Akhmedzhanov NM; Pavlova LI; Oganov RG
Bull Exp Biol Med; 2001 Apr; 131(4):321-4. PubMed ID: 11550015
[TBL] [Abstract][Full Text] [Related]
17. [Lipids, high density lipoprotein cholesterol and mortality in coronary and cerebral arteriosclerosis].
Nebieridze DV; Zhukovskiĭ GS; Deev AD; Akhmeteli MA; Zadoia AA
Ter Arkh; 1981; 53(1):60-2. PubMed ID: 7221911
[No Abstract] [Full Text] [Related]
18. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
19. [High density lipoprotein composition in moscovites with low and high HDL cholesterol level].
Ozerova IN; Metel'skaia VA; Perova NV
Ter Arkh; 2001; 73(9):34-8. PubMed ID: 11642078
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
